68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study-Reference-Cited by-同舟云学术

68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study

Published:2021-03 Issue:3 Volume:3 Page:e185-e194
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Bergmann Christina,Distler Jörg H W,Treutlein Christoph,Tascilar Koray,Müller Anna-Theresa,Atzinger Armin,Matei Alexandru-Emil,Knitza Johannes,Györfi Andrea-Hermina,Lück Anja,Dees Clara,Soare Alina,Ramming Andreas,Schönau Verena,Distler Oliver,Prante Olaf,Ritt Philipp,Götz Theresa Ida,Köhner Markus,Cordes Michael,Bäuerle Tobias,Kuwert Torsten,Schett Georg,Schmidkonz Christian

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. Wound repair and regeneration;Gurtner;Nature,2008

2. Scleroderma;Gabrielli;N Engl J Med,2009

3. Systemic sclerosis;Denton;Lancet,2017

4. Predictors of progression in systemic sclerosis patients with interstitial lung disease;Distler;Eur Respir J,2020

5. Systemic sclerosis-associated interstitial lung disease;Perelas;Lancet Respir Med,2020

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT;Frontiers in Oncology;2024-09-06

2. Update on Rheumatic Diseases in Clinical Practice;Radiologic Clinics of North America;2024-09

3. Evaluation of fibroblast activation protein‐specific PET/CT in a patient with post‐COVID pneumonitis;Respirology Case Reports;2024-09

4. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index;Arthritis & Rheumatology;2024-08-26

5. FAPI-PET/CT zur Quantifizierung der Gewebeantwort bei rheumatischen Erkrankungen;Zeitschrift für Rheumatologie;2024-07-20